Document Classification

Section Type: RESULTS

Text: The level of GMP140 [CT group : (17. 51 + / -2. 75) microg/L, DSM group : (16. 94 + / -2. 57) microg/L], vMF [CT group : (13. 64 + / -2. 37) microg/L, DSM group : (14. 14 + / -2. 17) microg/L] and CD62P/CD61 [CT group : (20. 24 + / -2. 64) %, DSM group : (19. 54 + / -2. 69) %] were elevated significantly in severe COPD patients with acute exacerbation compared to the control group before treatment [(11. 21 + / -1. 11) %, (9. 25 + / -1. 80) microg/L, (6. 13 + / -1. 17) microg/L, all P < 0. 01].